Purchase Order 75D30124P19805
- Not listed
- The Centers for Disease Control and Prevention (CDC) awarded Sino Biological US Inc., a foreign-owned small disadvantaged business and manufacturer of goods, a $249,050 firm fixed-price purchase order for protein production to support viral disease prevention and control efforts. The award has no set-aside designation. In addition to this prime federal contract, Sino Biological has received awards from other agencies such as the National Institutes of Health (NIH) for generating materials to aid...
- This firm fixed-price purchase order for approximately $54,700 was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Sino Biological US Inc. to support antiviral drug development efforts. Under the contract, Sino Biological will generate hybridoma cell lines and monoclonal antibodies targeting four viral proteins of priority pathogens identified by the Antimicrobial Resistance Coordination and Strategy Unit. The work includes providing...
- This $227,348.40 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the production of focused antibodies and DNA to support the CDC's Influenza Division in the development and characterization of Candidate Vaccine Viruses (CVVs) for influenza pandemic preparedness. This requirement is driven by the constant genetic changes in circulating and novel...
- The Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order contract worth $87,600 to Federon Procurement Solutions, a minority-owned, self-certified small disadvantaged business in Alexandria, Virginia. The contract is for the bulk production of oligonucleotides and synthetic genes to support the development of Candidate Vaccine Viruses (CVVs) at the CDC Influenza Division. This requirement was originally posted as an $87,600 Request for Quotations (RFQ)...
- This federal contract was awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Abclonal Science, Inc. (doing business as Abclonal Technology), a foreign-owned, self-certified small disadvantaged business. The $246,880.00 firm-fixed-price purchase order is for gene synthesis antibodies, with a completion date of August 30, 2020. The contract does not have a set-aside designation. Based on the agency and description, this contract...
- Genscript USA Inc. was awarded a $90,340 purchase order by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, Pennsylvania. Under the terms of the contract, Genscript will provide bulk antibody production services in support of the CDC's CVV (Comparative Vaccine Vector) program. Performance will take place at Genscript's facility in Chamblee, Georgia over the course of one year, from September 2022 through September 2023. The contract has a firm fixed price and no set-aside...
- The Centers for Disease Control and Prevention (CDC) awarded a $34,100.00 firm-fixed-price purchase order to Formulatrix, LLC, a foreign-owned, for-profit organization based in Bedford, Massachusetts. The contract is for the procurement of one Tangential Flow Filtration (TFF) system, along with training and installation qualification/operational qualification services. The TFF system will be used to purify and concentrate proteins, viruses, and RNA to support vaccine development needs at the...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order contract worth $246,699.00 to Genscript USA Inc., a for-profit biotechnology company. The contract is for the synthesis of plasmids and mutagenesis in support of research on critical vaccine viruses (CVV), with a completion date of September 22, 2024. Genscript, based in Piscataway, New Jersey, provides a range of molecular biology services to federal agencies,...
- This is a $54,000 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to MS Bioworks LLC, a for-profit limited liability company that provides protein mass spectrometry and proteomics services. The contract, identified as MS BIOWORKS MSB-DIA-03, is for an ultimate completion date of July 30, 2024. Based on the vendor's past federal contract awards, the services to be provided under this contract likely include quantitative proteomics analysis,...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, awarded a $24,999 firm-fixed-price purchase order to Sino Biological US Inc., a foreign-owned, self-certified small disadvantaged business, for scale and antibody production services. The award does not have a set-aside designation. Sino Biological US Inc. is a manufacturer of recombinant proteins and antibodies, and has previously received other federal contract awards from agencies such as the...
This $120,750 Firm Fixed Price purchase order was awarded to Sino Biological US Inc. by the Centers for Disease Control and Prevention (CDC) on September 28, 2024. The contract is for PROTEIN PRODUCTION FOR CVV (Candidate Vaccine Virus) and is set aside for Total Small Business. Sino Biological US Inc. is a foreign-owned, self-certified small disadvantaged business that manufactures biological goods. The company has a proven track record of providing proteins and other materials to support federal agencies' viral disease prevention, antiviral drug development, and COVID-19 research efforts. This contract contributes to the CDC's work in producing candidate vaccine viruses, which are a critical component of their viral disease control programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $120.8k | 9/5/24 |